Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics (Q42253103)
Jump to navigation
Jump to search
scientific article published on 13 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics |
scientific article published on 13 November 2013 |
Statements
1 reference
Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics (English)
1 reference
Srikanth Venkatraman
1 reference
Francisco Velazquez
1 reference
Stephen Gavalas
1 reference
Wanli Wu
1 reference
Kevin X Chen
1 reference
Anilkumar G Nair
1 reference
Frank Bennett
1 reference
Yuhua Huang
1 reference
Patrick Pinto
1 reference
Yueheng Jiang
1 reference
Oleg Selyutin
1 reference
Bancha Vibulbhan
1 reference
Qingbei Zeng
1 reference
Charles Lesburg
1 reference
Jose Duca
1 reference
Larry Heimark
1 reference
Hsueh-Cheng Huang
1 reference
Sony Agrawal
1 reference
Chuan-kui Jiang
1 reference
Eric Ferrari
1 reference
Cheng Li
1 reference
Joseph Kozlowski
1 reference
Stuart Rosenblum
1 reference
Neng-Yang Shih
1 reference
F George Njoroge
1 reference
13 November 2013
1 reference
1 reference
22
1 reference
1
1 reference
447-458
1 reference
Identifiers
1 reference
1 reference